Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 230 participants.
Also called NCT01212900
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 230 participants
- Registry
-
NCT01212900
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01212900. Randomized; single masking; primary purpose treatment. Start 2010-09-30 (registry gives no type); primary completion 2016-11-30 (actual). Results posted on 2018-10-31.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
- Condition
- Atherosclerosis
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Statins, HMG CoA
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct01212900- Content hash
88c1011f363359b17ffc5ec27406c3784102af53a3936f40fedc8b9c091634b1